Hartmann Group reports H1 sales increase of 3.0%; inco revenues up 7.8%, aided by Lindor acquisition




HEIDENHEIM, Germany, August 8, 2018-

The HARTMANN GROUP, a leading international supplier of medical and hygiene products, remains on track for growth in its anniversary year 2018. Group sales revenues grew by 3.0% to EUR 1.0368 billion in the first six months, in spite of the continuing negative impact of exchange rates. If the strength of the euro had not led to reductions in revenue, especially in the case of America and Asia, the Group's growth would actually have amounted to almost 5%. 

Earnings before interest and taxes (EBIT) came to EUR 61.1 million, which – as anticipated – was down 6.5% over last year’s figure. This arises from price pressure on the markets and higher regulatory costs, as well as expenditures in connection with structural and growth investments. For instance, in the past few months, HARTMANN has been expanding its sales organization considerably in Germany and France. Additionally, the company intensifies sales investments in the growing field of state-of-the-art wound treatment. With a positive net financial position of around EUR 45 million and an equity ratio of over 60%, HARTMANN remains on strong financial footing, allowing it to sustain investment momentum through the second half of the year. 


Not a subscriber?









TRY Nonwovens Markets
Newsletter TODAY!